927883-45-2

Basic information

• Product Name: 2-carbamoylpiperazine-1,4-dicarboxylic acid di-tert-butyl ester
• CAS NO: 927883-45-2
• Molecular Weight: 329.396
• Mol File: 927883-45-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-carbamoylpiperazine-1,4-dicarboxylic acid di-tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-carbamoylpiperazine-1,4-dicarboxylic acid di-tert-butyl ester(927883-45-2)
• EPA Substance Registry System: 2-carbamoylpiperazine-1,4-dicarboxylic acid di-tert-butyl ester(927883-45-2)

Safety Data

• Hazardous Substances Data: 927883-45-2(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1246030-06-7 2-(aminocarbonyl)-1-piperazinecarboxylic acid 1,1-dimethylethyl ester 
• 2762-32-5 piperazine-2-carboxylic acid 
• 181955-79-3 N,N'-di-tert-butyloxycarbonylpiperazine-2-carboxylic acid 

Downstream Products

• 924964-23-8 di-tert-butyl 2-cyanopiperazine-1,4-dicarboxylate 

Relevant articles and documents

N-(3-(5-(PYRIMIDIN-4-YL)THIAZOL-4-YL)PHENYL)SULFONAMIDE COMPOUNDS AND THEIR USES AS BRAF INHIBITORS

The present invention relates to N-(3-(5-(pyrimidin-4-yl)thiazol-4-yl)phenylsulfonamide compounds which are useful as inhibitors of protein kinases, more specifically BRAF or mutant forms thereof, to pharmaceutical composition comprising such compounds, and to uses of such compounds in the treatment or prevention of diseases associated with deregulated protein kinase activity, such as cancer.

Cinnamamide compounds as metabotropic glutamate receptor antagonists

The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where R1, R2, R3, A, X, and n are defined in the description. The invention also includes pharmaceutical composition